Theorem Clinical Research is a global provider of comprehensive clinical services with staff throughout the Americas, Europe and Asia-Pacific and a client base comprised of the world’s leading biopharmaceutical and medical device companies. With industry-leading experts, unparalleled therapeutic expertise and innovative, groundbreaking technology, Theorem is focused on analytic-based development, combination trials and personal data applications to simplify complex trials.
Through execution with full intent, Theorem applies focus, strength, energy and knowledge to simplify complex trials while providing customized design, flawless study conduct and superior clinical development for the drug, device and diagnostic industries.
Theorem is built on a long history of delivering exceptional services and support for all phases of clinical research. Before launching in 2011, Theorem operated as a subsidiary of Omnicare Inc., tracing its roots back to 1985. Today, Theorem is a global organization with 1,500+ employees located throughout more than 40 countries.
1985Omnicare Inc. launches.
2000Omnicare Inc. establishes Omnicare Clinical Research Inc.
2002Omnicare Clinical Research opens offices in Bangalore, India, and Tokyo, Japan, to further penetrate Asia-Pacific region.
2003Omnicare Clinical Research's PAGeR Business Unit is established to provide dedicated resources for conducting peri-approval (Phase IIIb and IV) trials and clinical research projects in seniors.
2004Omnicare Inc. acquires an additional CRO, Clinimetrics Research Associates Inc., and strengthens medical device trial capabilities.
2005Omnicare Inc. celebrates 20th anniversary.
2007Omnicare Clinical Research launches OmnieView University, a state-of-the-art eLearning Management System, providing targeted, online training to internal and external project members.
2008Client Placement Service is launched, bringing Omnicare Clinical Research professionals on site to client locations for extended assignments, formalized under the OmniTEAM® brand name.
2009Omnicare Clinical Research launches cardiovascular, oncology and vaccine therapeutic advisory teams, providing projects with additional support from a medical, operational, regulatory and cost-effective perspective.
2010Omnicare Clinical Research integrates operations with sister CRO, Clinimetrics Research Associates. This integrated approach results in increased therapeutic reach, an exchange of expertise and expanded global resources, coupled with specialization in focused business units designed to meet the specific needs of clients.
2011Omnicare Clinical Research and Clinimetrics Research Associates are acquired by Nautic Partners, LLC, a strategic growth private equity firm. As part of the move, Omnicare Clinical Research and Clinimetrics Research Associates become Theorem Clinical Research and rebrand as an independent company focused on delivering expert clinical trial expertise and support at every phase of drug and device development.
Today and TomorrowTheorem continues to grow in size and capability, forming strategic alliances with partners worldwide, launching new services and integrating new technologies with the addition of new services and optimization of others to drive the next generation of clinical research.